Meckiff, Benjamin James (2021). Evolution of the human CD4+ T cell response to Epstein-Barr virus infection - analysis of systemic and local immune responses. University of Birmingham. Ph.D.
|
Meckiff2021PhD.pdf
Text - Accepted Version Available under License All rights reserved. Download (4MB) | Preview |
Abstract
CD4+ T cells are essential for overall control of human virus infections, yet their multiple roles remain ill-defined at the single cell level, and most studies have focused solely on analysis of those present in the circulation. Using Epstein-Barr virus (EBV)-specific human leukocyte antigen (HLA) class II tetramers, we have studied the circulating functional and clonal evolution of circulating antigen-specific CD4+ T cell responses
during infection and analysed the CD4+ T cell response at the site of viral replication. We show that primary EBV infection, elicits an acute expansion of oligoclonal antigenspecific T helper-1 (TH1)-like CD4+ T cell populations in the blood that are armed with cytotoxic proteins and can respond immediately ex vivo to challenge with virus-infected B cells. Over time as the primary response contracts, we find that the resultant memory populations show (i) a marked decrease in cells expressing cytotoxic and activation markers, but (ii) increased TCR diversity as new clonotypes join those originally present, and (iii) increased cytokine polyfunctionality. Importantly, the cytotoxic CD4+ T cells responding to acute primary infection differed in their transcriptional program to the classically described CD4-CTLs that accumulate during chronic viral infections.
Moreover, we show that EBV infection seeds populations of tissue resident EBV-specific CD4+ T cells in the tonsil. These EBV-specific TRM which expresses cytotoxic proteins, are preferentially retained in the T cell zone and B cell follicles of the tonsils. These findings imply an important effector role for CD4-CTLs in acute EBV infection and at the site of EBV replication, emphasising the need to harness their potential in herpesvirus vaccine design.
Type of Work: | Thesis (Doctorates > Ph.D.) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Award Type: | Doctorates > Ph.D. | |||||||||
Supervisor(s): |
|
|||||||||
Licence: | All rights reserved | |||||||||
College/Faculty: | Colleges (2008 onwards) > College of Medical & Dental Sciences | |||||||||
School or Department: | Institute of Immunology and Immunotherapy | |||||||||
Funders: | None/not applicable | |||||||||
Subjects: | Q Science > QH Natural history > QH301 Biology | |||||||||
URI: | http://etheses.bham.ac.uk/id/eprint/11682 |
Actions
Request a Correction | |
View Item |
Downloads
Downloads per month over past year